Antibodies virus autoimmune liver disease evidence geographical heterogeneity reports occurrence antibodies hepatitis virus HCV patients autoimmune chronic active hepatitis AI-CAH sera UK Italian patients original anti-HCV assay Ortho novel anti-HCV assay UBI synthetic HCV peptides Italian patients AI-CAH anti-HCV-positive Ortho ELISA positive UBI assay UK patients AI-CAH HCV-positive Ortho ELISA positive UBI assay Italian patients AI-CAH UK patients anti-HCV-positive UBI assay Italian patients AI-CAH appear high frequency genuine exposure HCV whereas seropositivity Ortho HCV ELISA UK patients likely false-positive result findings important geographical and/or genetic influences autoimmune liver disease different populations 